Entegrion’s plasma technology gets $43.7M Defense Department contract

Blood technologies company Entegrion has been awarded a $43.7 million defense contract to develop one of its investigational blood products into a substitute for fresh frozen plasma. The Department of Defense will fund development of Resusix, Entegrion’s dehydrated human plasma. Resusix will become Entegrion’s first investigational new drug application filing. Research Triangle Park, North Carolina-based […]


Navy to study Entegrion’s blood technology as a life-saving fluid

North Carolina biotechnology company Entegrion is in line to receive up to $9.84 million from the U.S. Navy, which wants to develop two of the company’s investigational blood products into a single life-saving fluid for use in combat situations. The Navy extended an existing contract with Research Triangle Park, North Carolina-based Entegrion in order to […]

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.


N.C. biotech Entegrion licenses novel bandage to Beeken BioMedical

Updated 4:06 p.m. North Carolina life sciences company Entegrion has licensed its blood-clotting bandage to newly formed Chicago company Beeken BioMedical. Research Triangle Park-based Entegrion developed the bandage, called Stasilon, which is made of a proprietary weave of glass and bamboo fibers, two materials that promote clotting. Entegrion has received U.S. Food and Drug Administration […]